251 related articles for article (PubMed ID: 20238186)
1. Tumor grade-related thallium-201 uptake in chondrosarcomas.
Kaya GC; Demir Y; Ozkal S; Sengoz T; Manisali M; Baran O; Koc M; Tuna B; Ozaksoy D; Havitcioglu H
Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
[TBL] [Abstract][Full Text] [Related]
2. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
Jo O; Schlicht S; Slavin J; Di Bella C; Pang G; Powell G; Spelman T; Choong PF
Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cartilaginous tumors with 201Tl scintigraphy.
Higuchi T; Taki J; Sumiya H; Kinuya S; Nakajima K; Namura M; Tonami N
Ann Nucl Med; 2005 Apr; 19(2):95-9. PubMed ID: 15909488
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
Lee FY; Yu J; Chang SS; Fawwaz R; Parisien MV
J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
[TBL] [Abstract][Full Text] [Related]
6. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
Eefting D; Schrage YM; Geirnaerdt MJ; Le Cessie S; Taminiau AH; Bovée JV; Hogendoorn PC;
Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
[TBL] [Abstract][Full Text] [Related]
7. Bone and Tl-201 scintigraphy in a case of hereditary multiple exostoses.
Tani A; Tsuchimochi S; Nakabeppu Y; Nakajo M
Clin Nucl Med; 2001 Dec; 26(12):1028-31. PubMed ID: 11711707
[TBL] [Abstract][Full Text] [Related]
8. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.
Altay M; Bayrakci K; Yildiz Y; Erekul S; Saglik Y
J Orthop Sci; 2007 Sep; 12(5):415-23. PubMed ID: 17909925
[TBL] [Abstract][Full Text] [Related]
9. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
10. Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature.
Arsos G; Venizelos I; Karatzas N; Koukoulidis A; Karakatsanis C
Eur J Radiol; 2002 Jul; 43(1):66-72. PubMed ID: 12065124
[TBL] [Abstract][Full Text] [Related]
11. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula.
Kendell SD; Collins MS; Adkins MC; Sundaram M; Unni KK
Skeletal Radiol; 2004 Aug; 33(8):458-66. PubMed ID: 15221215
[TBL] [Abstract][Full Text] [Related]
12. Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.
Hendel HW; Daugaard S; Kjaer A
Clin Nucl Med; 2002 Sep; 27(9):622-4. PubMed ID: 12192277
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.
Geirnaerdt MJ; Hermans J; Bloem JL; Kroon HM; Pope TL; Taminiau AH; Hogendoorn PC
AJR Am J Roentgenol; 1997 Oct; 169(4):1097-104. PubMed ID: 9308471
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
16. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
17. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation.
Kaim AH; Hügli R; Bonél HM; Jundt G
Skeletal Radiol; 2002 Feb; 31(2):88-95. PubMed ID: 11828329
[TBL] [Abstract][Full Text] [Related]
18. Chondroid Tumors as Incidental Findings and Differential Diagnosis between Enchondromas and Low-grade Chondrosarcomas.
Afonso PD; Isaac A; Villagrán JM
Semin Musculoskelet Radiol; 2019 Feb; 23(1):3-18. PubMed ID: 30699449
[TBL] [Abstract][Full Text] [Related]
19. Scintigraphy of benign exostoses and exostotic chondrosarcomas.
Hudson TM; Chew FS; Manaster BJ
AJR Am J Roentgenol; 1983 Mar; 140(3):581-6. PubMed ID: 6600555
[TBL] [Abstract][Full Text] [Related]
20. Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.
Akoh CC; Craig E; Troester AM; Miller BJ
Iowa Orthop J; 2019; 39(1):185-193. PubMed ID: 31413693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
